It took me weeks to come to terms with the fact that there were no easy answers. I couldn't change the past or the diagnosis, so I focused on educating myself and becoming Tinslee's biggest advocate. We underwent all the necessary tests, scans, and procedures, and spent a year going in for lab work and check-ups.
Directory
Sudhir Borgonha
Translational Science Director | MD
Sudhir is a physician researcher with over 15 years of experience leading early stage projects and companies. Before coming to FARF, he was the Medical Director at Strand Genomics, where he was instrumental in developing customized gene panels in rare diseases and cancer, including launching a liquid biopsy test. He oversaw clinical reporting in collaboration with clinicians across the globe for over 5,000 patients per year, of which over a 1,000 were in rare diseases. As Translational Science Director, Sudhir leads development of FA translational science by working with academic and industry partners to pursue clinical research opportunities to better understand and treat FA. He manages translational projects including the development of a clinical registry and tissue bank.
A graduate of St. John’s Medical College, Bangalore and the Sloan School of Management, MIT, Sudhir is passionate about integrating emerging technologies into medicine. He is an aspiring writer and still has mixed feelings about why Bob Dylan won the Nobel prize in literature and Philip Roth didn’t.
The Latest
News & Events
The Fanconi Cancer Foundation (FCF) is excited to announce that Dr. Isis Sroka has been named CEO effective August 1, 2024. She succeeds Mark Quinlan who served as Executive Director since 2017 and recently announced his departure. Quinlan will continue in an advisory role with FCF through a transition period.
On May 24th, 2024, the FA Europe Network hosted its inaugural pan-European scientific meeting at the historic Saint-Louis Hospital in Paris, marking a significant milestone in international collaboration for Fanconi anemia (FA).